Back to Search
Start Over
Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
- Source :
-
The Journal of steroid biochemistry and molecular biology [J Steroid Biochem Mol Biol] 2021 Oct; Vol. 213, pp. 105954. Date of Electronic Publication: 2021 Jul 21. - Publication Year :
- 2021
-
Abstract
- Background: The present study was conducted to investigate the therapeutic effects of a potent polyphenol, fisetin, on the letrozole-induced rat model of polycystic ovary syndrome (PCOS).<br />Methodology: Twenty-four female Wistar rats (42 days old) were divided into four groups: control group (received carboxy methylcellulose (CMC 0.5 %)), PCOS group treated with letrozole (1 mg/kg), fisetin group received same dose of letrozole + fisetin (10 mg/kg), and metformin group received same dose of letrozole + metformin (300 mg/kg). At the end of the experiment, biochemical (glucose, lipid profile) and hormonal (insulin, testosterone, estradiol, and progesterone) parameters were analyzed. Histological examinations of ovaries were also conducted by hematoxylin and eosin (H&E) staining. Real-time polymerase chain reaction (PCR) and western blotting were carried out for cytochrome P450 17A1 (CYP17A1), sirtuin-1 (SIRT1), and 5' AMP-activated protein kinase (AMPK) gene expression in the ovaries. Furthermore, enzymatic activities of antioxidants including catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) in the ovaries were analyzed by colorimetric method.<br />Results: Letrozole administration resulted in a remarkable abnormality in biochemical and hormonal parameters. Fisetin normalized levels of glucose, lipid profile, homeostatic model assessment for insulin resistance (HOMA-IR), testosterone, estradiol, and progesterone. Moreover, fisetin increased expression levels of SIRT1 and AMPK, and decreased expression level of CYP17A1 in the ovaries. Additionally, fisetin showed protective effect by enhancing antioxidant activities of CAT, SOD, and GPx depleted secondary to induction of PCOS. Fisetin effects were comparable to metformin, as the standard drug used for treatment of PCOS.<br />Conclusion: Our results showed that, fisetin treatment caused significant alleviating effects by restoring PCOS-induced alterations in the key genes involved in energy homeostasis and antioxidant enzymes, suggesting that it may have a key role in combating with PCOS.<br /> (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Subjects :
- AMP-Activated Protein Kinases blood
AMP-Activated Protein Kinases genetics
Animals
Blood Glucose metabolism
Carboxymethylcellulose Sodium administration & dosage
Catalase blood
Catalase genetics
Disease Models, Animal
Estradiol blood
Female
Gene Expression
Glutathione Peroxidase blood
Glutathione Peroxidase genetics
Humans
Insulin blood
Letrozole toxicity
Metformin pharmacology
Ovary metabolism
Ovary pathology
Polycystic Ovary Syndrome blood
Polycystic Ovary Syndrome chemically induced
Polycystic Ovary Syndrome pathology
Progesterone blood
Rats
Rats, Wistar
Sirtuin 1 blood
Sirtuin 1 genetics
Steroid 17-alpha-Hydroxylase antagonists & inhibitors
Steroid 17-alpha-Hydroxylase blood
Steroid 17-alpha-Hydroxylase genetics
Superoxide Dismutase blood
Superoxide Dismutase genetics
Testosterone blood
Antineoplastic Agents, Phytogenic pharmacology
Flavonols pharmacology
Letrozole antagonists & inhibitors
Ovary drug effects
Polycystic Ovary Syndrome drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1220
- Volume :
- 213
- Database :
- MEDLINE
- Journal :
- The Journal of steroid biochemistry and molecular biology
- Publication Type :
- Academic Journal
- Accession number :
- 34298098
- Full Text :
- https://doi.org/10.1016/j.jsbmb.2021.105954